Cyclophosphamide for Nasopharyngeal Carcinoma
NCT02794077
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
56
Enrollment
OTHER
Sponsor class
Conditions
Recurrent Nasopharyngeal Undifferentiated Carcinoma
Stage IV Nasopharyngeal Undifferentiated Carcinoma
Interventions
DRUG:
Cyclophosphamide
Sponsor
The University of Hong Kong